Dilaudid and Ascorbate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilaudid (hydromorphone hydrochloride) and Ascorbate (vitamin c (ascorbic acid)). Common drug interactions include female genital tract fistula among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Dilaudid and Ascorbate. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Ascorbate?

Ascorbate has active ingredients of vitamin c (ascorbic acid). eHealthMe is studying from 1,446 Ascorbate users. Check the latest studies of Ascorbate.



On Aug, 09, 2026

17 people who take Dilaudid and Ascorbate together, and have interactions are studied.

Dilaudid and Ascorbate drug interactions.

What are the common drug interactions of Dilaudid and Ascorbate, by gender? *:

female:

  1. Female genital tract fistula (passage in genital tract of female)
  2. Frequent bowel movements
  3. Haematochezia (passage of stools containing blood)
  4. Oral candidiasis (fungal infection of mouth)
  5. Proctitis (inflammation of the rectum and anus)
  6. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
  7. Rectal haemorrhage (bleeding from anus)
  8. Vaginal discharge
  9. Nausea (feeling of having an urge to vomit)
  10. Pyrexia (fever)

male:

  1. Dehydration (dryness resulting from the removal of water)
  2. Dysgeusia (disorder of the sense of taste)
  3. Pyrexia (fever)
  4. Red blood cell count decreased
  5. Renal disorder (kidney disease)
  6. Sinusitis (inflammation of sinus)
  7. White blood cell count decreased
  8. Ear congestion
  9. Epistaxis (bleed from the nose)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Dilaudid and Ascorbate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cholecystitis chronic (long lasting infection of gallbladder)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Pulmonary embolism (blockage of the main artery of the lung)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  2. Nausea (feeling of having an urge to vomit)
  3. Pneumonia
  4. Pyrexia (fever)
  5. Red blood cell count decreased
  6. Sinusitis (inflammation of sinus)
  7. White blood cell count decreased
  8. Dehydration (dryness resulting from the removal of water)
  9. Dysgeusia (disorder of the sense of taste)
  10. Ear congestion

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Pyrexia (fever)
  3. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
  4. Procedural pain
  5. Weight decreased
  6. Back pain
  7. Decreased appetite
  8. Fall
  9. Fatigue (feeling of tiredness)
  10. Sinus disorder (disease of sinus)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 41.18%
  2. Allergies: 4 people, 23.53%
  3. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 23.53%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 17.65%
  5. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 17.65%
  6. Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 17.65%
  7. Joint Pain: 3 people, 17.65%
  8. Indigestion: 3 people, 17.65%
  9. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 17.65%
  10. Constipation: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and Ascorbate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dilaudid and Ascorbate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ascorbate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilaudid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ascorbate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride and vitamin c (ascorbic acid) (the active ingredients of Dilaudid and Ascorbate, respectively), and Dilaudid and Ascorbate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: